How COVID-19 Is Shaping The Digital Health Space

REGISTER HERE

The COVID-19 pandemic has fundamentally altered health priorities around the world. Across all sectors, organizations are engaging with digital solutions to tackle the spread of the virus and relying on data to make critical decisions around healthcare delivery and resource prioritization. In this webinar, panelists will discuss why we are seeing an increase in the use of digital during the COVID-19 pandemic, and how this extreme experience has awakened the world to the crucial infrastructure that needs to be in place in order to rapidly respond to future health emergencies.

MODERATOR

Bruno Villetelle
Head of Data and Digital Global Drug Development | Novartis

Bruno joined Novartis in April 2019 and leads the Data and Digital function for the company’s Global Drug Development (GDD) organization. He drives GDD’s data and digital vision, strategy and governance, and is focused on embedding data science and digital technologies to enhance asset development. Bruno has more than 30 years of experience spearheading digital and technology led innovation and new business model creation in the pharmaceutical, consumer health, and service industries. Prior to joining Novartis, he worked for Takeda Pharmaceutical Company Limited, a global top 10 pharmaceutical company, where he was Chief Digital Officer and oversaw more than 40 digital lighthouse programs. He also led the development of a portfolio of digital health companies offering game-changing digital solutions for patients and drug development.

Bruno has a Master of Science degree in Industrial Organization & Methodology and a Master of Science in Business Systems Management from the University of Lyon, France. He also has a Master of Engineering in Enterprise Information Systems from the Conservatoire des Arts et Métiers, France. In 2017, he was nominated one of the Top 40 healthcare transformers by MM&M (Medical, Marketing and Media).

PANELISTS

Maimuna (Maia) Majumder
 Instructor | Boston Children’s Hospital & Harvard Medical School

Dr. Maimuna (Maia) Majumder is a member of the ladder-rank faculty at the Computational Health Informatics Program (CHIP) based out of Harvard Medical School and Boston Children’s Hospital and a recent graduate of the Engineering Systems program at MIT’s Institute for Data, Systems, and Society (IDSS). In between her graduate studies and her current position at CHIP, Maia spent a year at the Health Policy Data Science lab at Harvard Medical School’s Health Care Policy department as a postdoctoral fellow. During her masters and doctoral studies at MIT, she was funded through a graduate fellowship at HealthMap computational epidemiology group.

Prior to Maia’s arrival at MIT, she earned a Bachelors of Science in Engineering Science (with a concentration in Civil and Environmental Engineering) and a Masters of Public Health in Epidemiology and Biostatistics at Tufts University. While at Tufts, Maia was a field researcher with the International Centre for Diarrheal Disease Research, Bangladesh (ICDDR,B), where she worked with clinic patients (and their data) to learn how to better tell their stories. Her current research interests involve probabilistic modeling, data science, and “systems epidemiology” in the context of public health, with a focus on causal inference for infectious disease surveillance using digital disease data (e.g. search trends; news and social media). She also enjoys exploring novel techniques for data procurement, writing about data for the general public, and creating meaningful data visualizations.

Helmi Zakariah, MD
CEO | Artificial Intelligence in Medical Epidemiology (AIME)

Dr Helmi Zakariah begins his journey with AIME as the Chief Operating Officer in Malaysia before being appointed as the Chief Executive Officer for AIME INC operation in the Asia-Pacific region effective from January 2nd, 2018. He currently oversees AIME’s operation, strategy and business development in Asia and the Pacific.

Dr Helmi started off his career as a clinician in Seremban General Hospital and subsequently a community clinic in Selangor, before he embarked on Public Health as a district program manager for National Tuberculosis Control Programme.

With an extensive background and experience in the field of Public Health, Dr Helmi was previously with Ministry of Health Malaysia where he co-pioneered the establishment of Global Health Division which strategizes, coordinate, and oversees Malaysia engagement with global health and strategic partnership with international NGO such as the WHO, MSF, ASEAN, South-South Cooperation Centre and the Union of International Cancer Control.

He also has a special interest in Trade & Public Health, and was regularly consulted to analyze multilateral trade agreements and its impact on national health policy space. In 2014, he participated in the Joint United-Nations Initiative for Migration in Asia Steering Committee, for his academic and advocacy works in the area of migrant health.

Dr Helmi Zakariah holds a Medical Degree from Russian Federation, and a Master in International Public Health from Liverpool, United Kingdom. He regularly shares his thoughts as speakers through global cooperative platforms such as Chatham House, WEF, and Commonwealth Digital Health Forum.